Lv3
320 积分 2024-11-23 加入
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial
6小时前
待确认
Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma
6小时前
已完结
Chimeric antigen receptor T-cell therapy and bispecific antibody sequence for large B-cell lymphoma: a systematic review and meta-analysis
3个月前
已关闭
Individualized Perioperative Blood Pressure Management in Patients Undergoing Major Abdominal Surgery The IMPROVE-multi Randomized Clinical Trial
4个月前
已完结
Induction of immune tolerance in living related human leukocyte antigen–matched kidney transplantation: A phase 3 randomized clinical trial
5个月前
已完结
Kidney Utilization in the Context of a Shifting Donor Landscape in the United States
5个月前
已关闭
Anti-BCMA CAR-T for the treatment of IgG4-related disease: clinical assessment and single-cell transcriptomic analysis
5个月前
已完结
Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis
6个月前
已完结
Xenotransplantation: Current Understanding of the Mechanism of Immune-Mediated Injury
6个月前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
9个月前
已完结
皖公网安备34019202002308
